Abrogation of IL-3 requirements and stimulation of hematopoietic cell proliferation in vitro and in vivo by carboxylic acids

Blood Cells, Molecules and Diseases

Volumn 23, Issue 3, 1997, Pages 434-442

  Boosalis, Michael S ^a   Ikuta, Tohru ^a   Pace, Betty S ^b   Fonseca, Silvana Da ^a   White, Gary L ^c   Faller, Douglas V ^a   Perrine, Susan P ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

Cell proliferation; Globin genes; Growth factors; Hematopoiesis; Mice; Primates

Indexed keywords

BUTYRIC ACID; CINNAMIC ACID DERIVATIVE; INTERLEUKIN 3; PHENOXYACETIC ACID DERIVATIVE; PROPIONIC ACID;

ARTICLE; CELL PROLIFERATION; GENE EXPRESSION REGULATION; HEMATOPOIESIS; HEMATOPOIETIC CELL; HEMOGLOBINOPATHY; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

PRIMATES;

EID: 0031427861     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1006/bcmd.1997.0162     Document Type: Article

References (43)

1. Stamatoyannopoulos J A, Neinhuis A W. Therapeutic approaches to hemoglobin switching in the treatment of hemoglobinopathies. Ann Rev Med. 43:1992;497-522.
2. Gallo E, Massaro P, Miniero R, David D, Tarella C. The importance of the genetic picture and globin synthesis in determining the clinical and hematological features of thalassemia intermedia. Brit J Haematol. 41:1979;211-221.
3. Karlsson S, Nienhuis A W. Developmental regulation of human globin genes. Ann Rev Biochem. 54:1985;1071-1108.
4. Wood W G, Weatherall D J. Developmental genetics of the human haemoglobins. Biochem J. 215:1983;1-10.
5. Yuan J, Angelucci E, Lucarelli G. Accelerated programmed cell death (apoptosis) in erythroid precursors of patients with severe β-thalassemia (Cooley's Anemia). Blood. 82:1993;374-377.
6. +. N Engl J Med. 307:1982;1469-1475.
7. Lowrey C H, Nienhuis A W. Brief report: treatment with azacitidine of patients with end-stage β-thalassemia. N Engl J Med. 329:1993;845-849.
8. Partington G A, Yarwood N J, Rutherford T R. Human globin gene transcription in injected Xenopus oocytes: Enhancement by sodium butyrate. EMBO J. 3:1984;2787-2792.
9. Faller D V, Perrine S P. Butyrate in the treatment of sickle cell disease and β-thalassemia. Curr Opin Hemat. 2:1995;109-117.
10. Perrine S P, Greene M F, Faller D V. Delay in the fetal globin switch in infants of diabetic mothers. N Engl J Med. 312:1985;334-338.
11. Glauber J G, Wandersee N J, Little J A, Gordon G D. 5′-Flanking sequences mediate butyrate stimulation of embryonic globin gene expression in adult erythroid cells. Mol Cell Biol. 11:1991;4690-4697.
12. Perrine S P, Rudolph A, Faller D V, Cohen R A, Chen S-J, Kan Y W. Butyrate infusions in the ovine fetus delay the biological clock for globin gene switching. Proc Natl Acad Sci USA. 85:1988;8540-8542.
13. Constantoulakis P, Papayannopoulou Th, Stamatoyannopoulos G. Alpha-amino-n-butyric acid stimulates fetal hemoglobin in the adult. Blood. 72:1988;1961-1967.
14. Liakopoulou E, Blau C A, Li Q L. Stimulation of fetal hemoglobin production by short chain fatty acids. Blood. 86:1995;3227-3235.
15. Perrine S P, Dover G H, Daftari P. Isobutyramide, an orally bioavailable butyrate analogue, stimulates fetal globin gene expressionin vitroin vivo. Brit J Haematol. 88:1994;555-561.
16. Pace B S, Li Q, Stomatoyannopoulos G. In vivo. Blood. 88:1996;1079-1083.
17. Safaya S, Ibrahim A, Reider R F. Augmentation of γ-globin gene promoter activity by carboxylic acids and components of the human β-globin locus control region. Blood. 84:1994;3929-3935.
18. Perrine S P, Miller B A, Faller D V. Sodium butyrate enhances fetal globin gene expression in erythroid progenitors of patients with Hb SS and β-thalassemia. Blood. 74:1989;454-460.
19. Perrine S P, Ginder G D, Faller D V. A short-term trial of butyrate to stimulate fetal-globin gene expression in the β-globin disorders. N Engl J Med. 328:1989;81-86.
20. Atweh G, Dover G J, Faller D V, Stamatoyannopoulos G, Fournarakis B, Perrine S P. Sustained hematologic response to pulse butyrate therapy in beta globin disorders. Blood. 88:1996;495a.
21. Fibach E, Prasanna P, Rodgers G P, Samid D. Enhanced fetal hemoglobin production by phenylacetate and 4-phenylbutyrate in erythroid precursors derived from normal donors and patients with sickle cell anemia and β-thalassemia. Blood. 82:1993;2203-2209.
22. Toscani A, Soprano D R, Soprano K J. Molecular analysis of sodium butyrate-induced growth arrest. Oncogene Res. 3:1988;223-238.
23. 1. J Cell Biochem. 21:1983;239-247.
24. 11. J Cell Phys. 145:1990;46-52.
25. Torkelson S, White G L, Phipps K. Erythroid progenitor proliferation is stimulated by phenoxyacetic and phenylalkyl acids. Blood Cells Mol Dis. 20:1996;150-158.
26. Scher G D, Ginder G D, Little J, Yang S, Dover G J, Olivieri N F. Extended therapy with intravenous butyrate in patients with beta-hemoglobinopathies. N Engl J Med. 224:1995;1606-1610.
27. Dover G J, Brusilow S, Charache S. Induction of fetal hemoglobin production in subjects with sickle cell anemia by oral sodium phenylbutyrate. Blood. 84:1994;339-343.
28. Collins A F, Pearson H A, Giardina P, McDonagh K T, Brusilow S W, Dover G J. Oral sodium phenylbutyrate therapy in homozygous β-thalassemia: a clinical trial. Blood. 85:1995;43-49.
29. Greenberger J S, Sakakeeny M A, Humphries R K, Eaves C J, Eckner R J. Demonstration of permanent factor-dependent multipotential (erythroid/ neutrophil/ basophil) hematopoietic progenitor cell lines. Proc Natl Acad Sci USA. 80:1983;2931-2935.
30. Valtieri M, Tweardy D J, Caracciolo D. Cytokine-dependent granulocytic differentiation. Regulation of proliferative and differentiation responses in a murine progenitor cell line. J Immunol. 138:1987;3829-3835.
31. Askew D S, Ihle J N, Cleveland J L. Activation of apoptosis with enforced myc expression in myeloid progenitor cells is dominant to the suppression of apoptosis by interleukin-3 or erythropoietin. Blood. 82:1993;2079-2087.
32. Patel G, Tantravahi R, Oh I-H, Reddy E P. Transcriptional activation potential of normal and tumor-associated myb isoforms does not correlate with their ability to block G-CSF-induced terminal differentiation of murine myeloid precursor cells. Oncogene. 13:1996;1197-1208.
33. Crotta S, Nicholis S, Ronchi A. Progressive inactivation of the expression of an erythroid transcriptional factor in GM- and G-CSF dependent myeloid cell lines. Nucleic Acids Res. 18:1990;6863-6869.
34. Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:1987;156-159.
35. Ikuta T, Kan Y W. In vivo. Proc Natl Acad Sci USA. 88:1991;10188-10192.
36. Ikuta T, Papayannopoulou T, Stamatoyannopoulos G, Kan Y W. Globin gene switching:invivo. J Biol Chem. 271:1996;14082-14091.
37. Chen C Y, Faller D V. Direction of p21(ras)-generated signals towards cell growth or apoptosis is determined by protein kinase C and Bcl-2. Oncogene. 11:1995;1487-1498.
38. Nicoletti I, Migliorati G, Pagliacci M C, Grignani F, Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Meth. 139:1991;271-279.
39. Pace B, Li Q, Peterson K, Stamatoyannopoulos G. α amino-n-butyric acid cannot reactivate the silenced gamma globin gene of the beta locus YAC transgenic line. Blood. 84:1994;4344-4353.
40. Tsuchiya N, Hayashi H, Naruse H, Takagi N. Higher performance liquid chromatography of carboxylic acids using 4 bromomethyl-7-acetoxycoumarin as a fluorescent reagent. J Chromatogr. 234:1982;121-130.
41. Nagel R L, Vichinsky E, Shah M. F-reticulocyte response in sickle cell anemia treated with recombinant human erythropoietin: a double-blind study. Blood. 81:1993;9-14.
42. Rodgers G P, Dover G J, Uyesaka N, Noguchi C T, Schechter A N, Nienhuis A W. Augmentation by erythropoietin of the fetal-hemoglobin response to hydroxyurea in sickle cell disease. N Engl J Med. 328:1993;73-80.
43. Constantoulakis P, Knitter G, Stamatoyannopoulos G. On the induction of fetal hemoglobin by butyrates:in vivoin vitro. Blood. 74:1989;1963-1971.